Authors/Disclosures
|
Michael J. Pontecorvo, PhD
(Avid Radiopharmaceuticals)
|
Dr. Pontecorvo has received personal compensation for serving as an employee of Eli Lilly. Dr. Pontecorvo has stock in Eli Lilly. |
|
Christopher Clark, MD
(Avid Radiopharmaceuticals)
|
No disclosure on file |
|
|
No disclosure on file |
|
Eva K. Ritzl, MD, MBA, FRCP (Glasgow), FAAN
(HSS)
|
Dr. Ritzl has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for various law firms. Dr. Ritzl has a non-compensated relationship as a Advocacy committee co-chair and CPT and RUC representation with ACNS that is relevant to AAN interests or activities. Dr. Ritzl has a non-compensated relationship as a Health Policy committee member with AAN that is relevant to AAN interests or activities. Dr. Ritzl has a non-compensated relationship as a AAN HOD Alternate Delegate with AAN that is relevant to AAN interests or activities. Dr. Ritzl has a non-compensated relationship as a Epic Neurosciences steering board with Epic that is relevant to AAN interests or activities. |
|
|
No disclosure on file |
|
Daniel Skovronsky, MD, PhD
|
No disclosure on file |
|
Mark A. Mintun, MD
|
Dr. Mintun has received personal compensation for serving as an employee of Eli Lilly & Co. |